Cargando…
Remission of an HHV8-related extracavitary primary effusion lymphoma in an HIV-positive patient during antiretroviral treatment containing dolutegravir
BACKGROUND: Human herpes virus 8 (HHV8) is the causative agent of Kaposi’s sarcoma and has been associated with an increasing number of hematologic diseases such as primary effusion lymphoma (PEL) (both classic and extracavitary form), multicentric Castleman disease and the germinotropic lymphoproli...
Autores principales: | Campogiani, Laura, Cerva, Carlotta, Maffongelli, Gaetano, Teti, Elisabetta, Pupo, Livio, Vaccarini, Sara, Cantonetti, Maria, Pennica, Alfredo, Andreoni, Massimo, Sarmati, Loredana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660660/ https://www.ncbi.nlm.nih.gov/pubmed/31351487 http://dx.doi.org/10.1186/s12981-019-0230-6 |
Ejemplares similares
-
Abnormal elevation of international normalized ratio in a patient during the coadministration of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide and warfarin: a case report
por: Malagnino, Vincenzo, et al.
Publicado: (2019) -
Extracavitary Manifestation of Primary Effusion Lymphoma as a Right Atrial Mass
por: Marak, Creticus P., et al.
Publicado: (2013) -
Extracavitary primary effusion lymphoma recurring with syphilis in an HIV-infected patient
por: Sohail Ahmed, Darakhshan, et al.
Publicado: (2020) -
A Rare Case of Extracavitary Primary Effusion Lymphoma in the Bladder and Ureter
por: Tong, Jiankun, et al.
Publicado: (2020) -
HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy
por: Malagnino, Vincenzo, et al.
Publicado: (2019)